AUCTORES
Globalize your Research
Research Article
*Corresponding Author: Ariane Keto, Ph.D., Department of Pediatrics, University Clinics of Kinshasa.
Citation: Keto MA, Tshilolo L, Budiongo NA, Mfulani G, Mafuta E. et al (2022) Impact of G6pd Deficiency on Sickle Cell Disease in Children in Kinshasa Hospitals: a Case-Control Study. J. Biomedical Research and Clinical Reviews. 7(3); DOI:10.31579/2692-9406/135
Copyright: © 2022 Ariane Keto, this is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received: 09 November 2022 | Accepted: 16 December 2022 | Published: 23 December 2022
Keywords: G6PD deficiency; sickle cell disease; child and kinshasa
Background and aim: Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency and sickle cell disease are two genetic diseases of the red blood cell that both cause hemolytic anemia. The objective of this study is to determine the clinico- biological impact of G6PD deficiency on sickle cell disease in childrenin Kinshasa.
Materials and method: This is a case-control analytical study of 103 G6PD-deficient sickle cell patientsand 309 non-G6PD- deficientsickle cell patients. Analysis of G6PD activitywas performed by ELISA, and hemoglobin electrophoresis by capillaris to confirm sickle cell disease.For all children, sociodemographic, clinical and biological variables were analyzed.
Results: The mean age of sickle cell deficient and non-deficient patients was 9.82±4.5 years and 9.48±3.8 years respectively. There were slightly more female sickle cell deficient patients (55.2%) while in the non- deficient group, there was a male predominance (51.8%) but no statistically significant difference (p>0.05). All morbid events occurring in sickle cell patients were greater in the G6PD deficiency group (p˂0.05). Evaluated antecedent complications occurringin sickle cell patients wereassociated with G6PD deficiency (p˂0.05),except for stroke.No statistically significant difference was noted in physicalsigns between sicklecell deficient and non-deficient groups(p>0.05). The hemogramshowed no difference between the two groups in steady state and the hemolysis markers evaluated also showed no significant differences in steady state (p>0.05) between the two groups.
Conclusion: G6PD deficiency aggravates the acute clinical manifestations and complications of sickle cell disease withoutaffecting the occurrence of stroke. And has no impact on the hematological parameters of sickle cell disease children in stationary phase.
Sickle cell disease and Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency are two geneticdiseases of the red blood cell mainlydescribed in Sub- Saharan Africa and in particular in DRC. These two abnormalities are responsible for hemolytic anemia [1]. The genes involved are located on different chromosomes and therefore these two diseases are transmitted independently althoughthey may be associated. Some authors believe thatG6PD deficiency has little or no impact on sickle cell disease while others believe that it worsens the clinical and biological profiles of sickle cell disease [2].
This comorbidity has been the subject of several scientific publications without showing an increase in the number of hemolytic crises, infectious episodes, and transfusions and chronic complications, or a lack of influence on the severityof the disease in such a combination [3-5]. Some authors believe that G6PD deficiency would have a protective effect since the deficiency of enzymatic activitycould contribute to the prematuredisappearance of red blood cells, which would result in the release of a new generation of young circulating cells. Piomelli et al. in Kenya in 1972 foundthat these two anomalies seemed to attenuate each other: sickle cell disease made the enzyme deficiency less apparent to the point that the deficientgenotype seemed to be masked[6].
Several authors have found that G6PD deficiency does not worsen the clinical and biological status of sicklecell patients; these include Firemponget al. in Ghana in 2016 and Diop et al. in Senegal in 2005 [3,7]. Others on the other hand have found that G6PD deficiency worsens the diseasestate of sickle cell patients: including: Bernaudin et al, in France in 2018, Benkerouet al , in France in 2013, Lohit et al , in India in 2019, Mounkaila et al , in Niger in 2015 and Bouangaet al , in Congo in 1998 [2, 8-11].
These different studies sufficiently demonstrate the high prevalence of the comorbidity of G6PD deficiency and sickle cell disease mainly in Africa. In the DRC, no study has been conducted on this comorbidity, yet it is one of the countries most affected by G6PD deficiency. Moreover, it is a country located in the sickle cell belt of Central Africa wheresickle cell disease and malaria endemically [12, 13]. In addition, there is a high frequency of self- medication, particularly with antimalarial drugs, which are oxidizing molecules, exposing to acute hemolytic crises in case of G6PD deficiency (Quinine, Chloroquine, Mefloquine, Halophantrine) [14-19].
Thus, given the high prevalence of sickle cell disease - G6PD deficiency comorbidity and the high frequencyof self-medication, we found it appropriate to undertake the present study, the objective of which is to determine the clinico-biological impact of G6PD deficiency on sickle cell disease among children in Kinshasa.
Nature, settingand period of study
This is a case-control study, which consisted of determining the clinico- biological impact of G6PD deficiency on sickle cell disease in children recruited as an active thread in medical facilities in Kinshasa. It covered the periodfrom June 2017 to June 2019, a duration of 2 years.
Population and sampling
Study hospitals were selected by convenience sampling. The consecutive selection method, in active file, was used to identify the children to be submitted to the inclusion criteria. The first group consisted of homozygous G6PD- deficient sickle cell childrenconfirmed by hemoglobin electrophoresis or molecular testing, aged 6 months to ≤18 years of age recruited in the active file, and followed up as an outpatient in the selected hospitals, and the second group consisted of age- and sex-matched nondeficient sickle cell children recruited in the same setting as the first group, i.e., one case for every three controls [20].
Variables of interest
The variables evaluated based on the clinical and biological manifestations of sickle cell disease were sociodemographic data (age, gender, origin),clinical variables (the notion of coca cola urine emission, the number of previous transfusions, the number of previous vaso-occlusive crises, the number of infectious episodes,the history of complications: priapism,aseptic necrosis of the femoral head, notion of stroke, notion of malleolarulcer, physical signs) and biological data (determination of G6PD enzyme activity, complete blood count, total bilirubin) [12, 13,14].
The samples were analyzed at the laboratory of the training and health support center (CEFA) and the Monkole hospital Center.
Conduct of the study
All childrenincluded in the study were identified using medical recordsand contacted to participate in the study. Children who met the inclusion criteriawere first given a clinical examination that included a history and physical examination. The elements collected during the clinicalexamination made it possible to set up an ad hoc questionnaire. Acute sickle cell crises were assessedby the average annual numberrequiring emergency admissionover the past 2 years (14). A physicalexamination, including weightmeasurement using a scale while undressed; height measurement using a horizontal scale in a supine or standing position according to age, with feet together.
Then, we took blood samples from each child. A 5 ml sample of venous blood was taken in two tubes;one dry for biochemical analysis,and the otherwith anticoagulant (EDTA) to carry out the haemogram, the determination of G6PD enzymatic activity by the ELISA method as well as haemoglobin electrophoresis; These tubes were stored at 4°C until the analysiswas performed and a blood sample was taken on Whatman filter paper withconventional FTATM cards for G6PD. The samples collected were coded and immediately sent to the CEFA and Monkole Hospital laboratories.
Data processing and analysis
All data were collectedand entered on Epi info 7, transported to Excel 2010spreadsheet, analyzed with SPSS for Windows version 22.0, and presented in tablesand graphs.
Continuous quantitative variables with a normal distribution were presented as means ± standard deviation; those with an anomalous distribution, as median (interquartile range). Categorical variableswere described as absolute and relative frequency (%).The comparison of the means or medians of the two groups was made, as appropriate, using the Student’s T test or the Mann Whitney U test; the Pearson Chi-square test, the Fisher’sexact test or the trend test were used to compare the proportions. The factors associated with G-6-PD deficiency were sought using the logistic regression test. The odds ratio and the 95% confidence intervals were represented and allowed to measure this association. For all the tests used,the threshold of statistical significance was p< 0>
Ethical considerations
The protocol of this work was submitted to the Ethics Committee of the School of Public Health and obtained approvalunder the number ESP/CE/028/2019. This work was conducted in strict compliance with the fundamental principles of ethics. Informed consent was obtained from the parents or guardians of the childrenby means of a writtenform after explanation of the purposeand implications of the study,the observations to be made, andthe benefits and risks forthe child.
Sociodemographic characteristics of the study population Clinicalinformation of the study population Clinical profile of G6PD deficient and non-G6PD deficient children with sickle cell disease biological information Factors associated with G6Pd deficiency
Table 1: Description of the study population
Table 2: Clinical information of G6PD-deficient and non-deficient children with sickle cell disease.
Table 3: Physical signs of G6PD-deficient and non-deficient childrenwith sickle cell disease.
Table 4: Biological data of sickle cell patients according to their G6PD deficiency status or not
The association between sickle cell diseaseand G6PD deficiency is very high in regions of high malaria endemicity, particularly in sub-Saharan Africa. The Democratic Republic of Congo (DRC) is no exception.
Clinically, our study showed that all morbid manifestations (the number of transfusion episode, coca- cola urine emission, infectious episode and vaso- occlusive crises) occurring in sickle cell patients were greater in the group with G6PD deficiency (p˂0.05). Previous complications (osteomyelitis, malleolar ulcer, and priapism) evaluated occurring in sickle cell patients were associated with G6PD deficiency (p˂0.05), with the exception of stroke. No statistically significant difference had been noted for physical signs between sickle cell deficient and nondeficient groups (p>0.05).
Our resultsagree with thoseof Mathula et al, in 2012 in the USA, Benkerou et al, (2013)as well as Bernaudin et al, in France in 2018, Lohit et al, in Indiain 2019, Mounkaila et al, in 2015 in Niger, and Bouanga et al, in 1998 in Congo, who reported that there were more transfusions in the G6PD- deficient sickle cell group, but found no significant difference in vasoocclusive crises and infectious episodes [2, 8-11, 21].
In contrast, Foluke et al. in 2019 in Nigeria, Diop et al. in 2005 in Senegal, Simpore et al. in Burkina Faso in 2007, Gbadoe et al. in Togo in 2001, and Firempong et al. in 2016 in Ghana found no significant difference in clinicalparameters between G6PD-deficient and non-G6PD- deficient sickle cell disease[3-5,7,22].
We can justify these discrepancies by the fact that the sickle cell haplotype found in the DRC, which is the Bantu haplotype, is the most severe form, in contrast to the Senegal, Benin, Cameroon and Arab-Indian haplotypes; and the variant of G6PD deficiency found in Africansassociated with sicklecell disease is type A which is a geneticform of less severity contraryto variants B (Mediterranean), Mahidol,Canton, Guadalajara, BeverlyHills, and Nashvillewhich are more found in America, Europeand Asia and which are more severeforms [23, 24].
Indeed, the disorders related to G6PD deficiency and sickle cell disease are due to the oxidative effect,which is an imbalance betweenthe production of free radicalsand the body'sability to detoxifytheir harmful effectdue to the neutralization through antioxidants. Free radicals are usually formed during normal metabolic reactions, but the body manages to detoxify them and decrease their level in the cell through the antioxidant effect. Sickle cell patientsproduce a fair amount of free radicalsresponsible for clinicalmanifestations and complications causing several organ damages including vaso-occlusive disorders [9, 25]. These free radicals also cause damage to membrane proteinsand lipids leadingto destruction of RBCs resultingin hyperhemolysis attacksand other morbid manifestations in sickle cell children [26].
There is still much controversy to this day about the impact of G6PD deficiency on sickle cell disease. This is the case of Piomelli et al, (1972), who argue that these two abnormalities seem to be mutually attenuating: sickle cell disease making the deficiency enzyme to the extent that the deficient genotypeappears to be masked[6].
The discrepancies and similarities found in the literature can also be explained by various phenomena that influence the course of sickle cell disease. We mention the hereditary persistence of fetal hemoglobin, the association with alpha thalassemia and the haplotype membership; all these elementswere not sought in our study[27, 28].
Referring to the biological data of the studied children, the blood count as well as the hemolysis markersshowed no difference between the two groups taken in steady state (p>0.05).
These observations meet those of Diop et al. in Senegal, Firempong et al. in Ghana in 2016 [3, 7]. However, Mehdi et al, in the USA in 2010, Bernaudinet al, (2018), and Benkerou et al, (2013) in France, as well as Lohit et al, in India in 2019, Foluke et al, in Nigeria in 2019, found that G6PD-deficientsickle cell patients had lower hemoglobin levels and elevated reticulocytes [2,4,10,29].
This is justified by the fact that in our study, as in the other African studies that found similar results to ours, the biological parameters were evaluated in a steady state,our patients had been in a stablestate for aboutthree months beforeour visit.
It is described that in case of hemolysis, there is a decrease in thenumber of RBCs, which also results in a decrease in the hemoglobin level, leading to marrow activation with an increasein the number of reticulocytes, which are immature RBCs; this would justify the increased episodes of hemolysis and anemia in G6PD- deficient sickle cell patients.
Our results should not obscure the fact that the association of sickle cell diseaseand G6PD deficiency carries obvious potential risks. Indeed, most of the drugs used by sickle cell patients are oxidizing and therefore likely to cause hemolysis in deficient patients. It is therefore useful to screen sickle cell patients for G6PD deficiency in order to derive preventive and therapeutic measures.
Study limitations and strengths Study limitation
The single measurement of biological parameters may have led to the under or overestimation of thevalues obtained.
Strength of the study
Beyond its limitations, the present study has, nevertheless, some strengths. It is the very first large study, which evaluates, through 4 health districts of the city and province of Kinshasa, the frequency and the clinico-biological impact of G6PD deficiency in children with sickle cell disease in DRC. This will certainly contribute to raising awareness in the management of these patients.
The present study aimed to determine the impact of G6PD deficiency on sickle cell disease in children in Kinshasa. Thus,the study showedthat G6PD deficiency is associated with acute clinicalmanifestations as well as complications of sickle cell patients, including: the occurrence of vaso occlusive crises,malleolar ulcer, osteomyelitis, aseptic necrosis of the femoral head, and priapism without influencing the occurrence of stroke. And it has no impact on the hematological parameters of sicklecell children in stationary phase. Hence the need to systematically search for G6PD deficiency in sickle cell patientsin order to take adequatepreventive measures in relation to the possible use of oxidizing drugs.
Conflict of interest: No conflicts of interest have been declared by the authors.
Authors' contributions: Ariane KETO and René NGIYULU conceived, collected, interpreted, wrote and correctedthe manuscript. Gibency Mfulani and Eric Mafuta analyzed the data, read and corrected the article. Joseph BODI, Léon TSHILOLO, Loukia Aketi and Aléine BUDIONGO supervised, interpreted and corrected the article. Balthazar PHOBA and Yves MUZINGAanalyzed the samplesin the laboratory of the Monkole HospitalCenter. All authorsread and approvedthe final versionof the article.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
Clinical Cardiology and Cardiovascular Interventions, we deeply appreciate the interest shown in our work and its publication. It has been a true pleasure to collaborate with you. The peer review process, as well as the support provided by the editorial office, have been exceptional, and the quality of the journal is very high, which was a determining factor in our decision to publish with you.
The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews journal clinically in the future time.
Clinical Cardiology and Cardiovascular Interventions, I would like to express my sincerest gratitude for the trust placed in our team for the publication in your journal. It has been a true pleasure to collaborate with you on this project. I am pleased to inform you that both the peer review process and the attention from the editorial coordination have been excellent. Your team has worked with dedication and professionalism to ensure that your publication meets the highest standards of quality. We are confident that this collaboration will result in mutual success, and we are eager to see the fruits of this shared effort.
